HealthWise KnowledgeBase
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) for Chronic Hepatitis B
How It Works
Nucleoside reverse transcriptase inhibitors (NRTIs) are medicines that slow the ability of the Reference hepatitis B Opens New Window virus (HBV) to multiply in the body. They are taken as pills once a day for at least a year, and usually much longer. Entecavir is also available as a liquid that you swallow.
Adefovir, entecavir, telbivudine, and tenofovir are approved by the U.S. Food and Drug Administration (FDA) for use in adults. Lamivudine is approved for use by adults and by children ages 2 to 17.
| By: | Reference Healthwise Staff | Last Revised: October 29, 2012 |
| Medical Review: | Reference Kathleen Romito, MD - Family Medicine
Reference W. Thomas London, MD - Hepatology |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
